We greatly value our faculty's scholarly contributions and are proud to honor their accomplishments.
Daniel Engelman, MD
Dr. Daniel Engelman, Associate Professor of Surgery at UMMS-Baystate, and Medical Director of the Heart, Vascular and Critical Care Units at Baystate Medical Center, has been forging efforts to improve the health of cardiac surgery patients in his role as president of ERAS® (Enhanced Recovery After Surgery) Cardiac—an international non-profit society with a mission to optimize the perioperative care of cardiac surgical patients through collaborative discovery, analysis, expert consensus, and dissemination of best practices. He has overseen the creation of an executive board, advisory board, and a subject matter panel of 40 international experts for ERAS® Cardiac.
With his colleagues within ERAS® Cardiac, Dr. Engelman has organized symposia at The American Association of Thoracic Surgeons Annual Meeting for the last two years on the advantages of superior perioperative care such as optimizing a patient’s nutritional status and addressing smoking cessation prior to surgery. This year, he was also asked to organize symposia at the International European Association of Cardiothoracic Surgery in Milan and at the World Congress on Enhanced Recovery in Stockholm.
Dr. Engelman and his clinical team are optimizing care for our own patients, particularly around the pre-habilitation component of treatment, by embracing best practices promulgated by ERAS® Cardiac.
Esra Caylan, MD
Dr. Esra Caylan, Assistant Professor of Pediatrics at UMMS-Baystate, published an article in the June 2018 issue of The Journal of Pediatrics that compared the characteristics and severity of respiratory disease in children testing positive for enterovirus D68 (EV-D68) and for human rhinovirus (RhV).
“Comparison of the Severity of Respiratory Disease in Children Testing Positive for Enterovirus D68 and Human Rhinovirus” found that children with EV-D68 appeared to have more severe respiratory disease on admission than children with RhV as evidenced by higher rates of fever, wheezing, bronchodilator use, and pediatric intensive care unit admission. Despite the initial difference in severity, no significant difference in length of stay was found, suggesting that patients with EV-D68 recovered as quickly as other groups.
There are many viruses causing respiratory disease in children but there is inadequate information to help differentiate, manage, or prevent these infections. By comparing EV-D68 with RhV infections, the investigators hope to elucidate clinical differences between these two disease processes. There was a nationwide outbreak of EV-D68 associated with severe respiratory illness in 2014.
Citation: Caylan E, Weinblatt E, Welter J, Dozor A, Wang G, Nolan SM. Comparison of the severity of respiratory disease in children testing positive for enterovirus d68 and human rhinovirus. The journal of pediatrics. 2018;197:147-153. doi:10.1016/j.jpeds.2018.02.027. (Read the Abstract)
Annual Weinberg Award for Academic Excellence
The Weinberg Family Award for Academic Excellence is awarded annually to an individual whose innovative research, publications, or leadership of a national academic organization have brought honor to Baystate Health.